Resona Asset Management Co. Ltd. Purchases Shares of 4,019 Maximus, Inc. (NYSE:MMS)

Resona Asset Management Co. Ltd. acquired a new position in shares of Maximus, Inc. (NYSE:MMS) in the fourth quarter, Holdings Channel reports. The institutional investor acquired 4,019 shares of the health services provider’s stock, valued at approximately $300,000.

Other hedge funds and other institutional investors also recently made changes to their positions in the company. Norges Bank acquired a new stake in Maximus during the 4th quarter valued at approximately $71,443,000. Vanguard Group Inc. increased its position in shares of Maximus by 3.2% during the fourth quarter. Vanguard Group Inc. now owns 6,548,284 shares of the health services provider’s stock worth $488,829,000 after buying an additional 205,564 shares during the period. Reinhart Partners LLC. raised its position in shares of Maximus by 43.5% in the 4th quarter. Reinhart Partners LLC. now owns 551,146 shares of the health services provider’s stock worth $41,143,000 after acquiring an additional 167,019 shares in the last quarter. Ruffer LLP acquired a new position in shares of Maximus in the 4th quarter valued at about $10,266,000. Finally, Barclays PLC boosted its position in shares of Maximus by 285.1% during the 3rd quarter. Barclays PLC now owns 170,971 shares of the health services provider’s stock valued at $15,927,000 after purchasing an additional 126,573 shares in the last quarter. 97.21% of the stock is owned by institutional investors and hedge funds.

Insiders Place Their Bets

In other news, insider Ilene R. Baylinson sold 14,500 shares of the business’s stock in a transaction dated Wednesday, February 19th. The shares were sold at an average price of $68.14, for a total transaction of $988,030.00. Following the completion of the sale, the insider now directly owns 2,512 shares of the company’s stock, valued at $171,167.68. The trade was a 85.23 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at this link. Also, Director Jan Madsen sold 2,439 shares of the firm’s stock in a transaction dated Tuesday, March 18th. The shares were sold at an average price of $67.71, for a total transaction of $165,144.69. Following the completion of the transaction, the director now directly owns 18,097 shares in the company, valued at approximately $1,225,347.87. The trade was a 11.88 % decrease in their position. The disclosure for this sale can be found here. Corporate insiders own 1.60% of the company’s stock.

Analysts Set New Price Targets

Several brokerages have issued reports on MMS. StockNews.com lowered Maximus from a “buy” rating to a “hold” rating in a research note on Friday, February 14th. Raymond James upgraded shares of Maximus from a “market perform” rating to an “outperform” rating and set a $90.00 target price on the stock in a research report on Thursday, January 2nd.

Maximus Price Performance

Shares of NYSE MMS opened at $68.41 on Friday. The company has a current ratio of 1.72, a quick ratio of 1.72 and a debt-to-equity ratio of 0.82. The firm’s 50-day moving average price is $67.90 and its 200-day moving average price is $76.15. The firm has a market capitalization of $3.87 billion, a P/E ratio of 14.71 and a beta of 0.68. Maximus, Inc. has a 1-year low of $63.77 and a 1-year high of $93.97.

Maximus (NYSE:MMS) last announced its quarterly earnings results on Thursday, February 6th. The health services provider reported $1.61 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.39 by $0.22. Maximus had a return on equity of 21.95% and a net margin of 5.28%. Equities research analysts anticipate that Maximus, Inc. will post 6.15 earnings per share for the current fiscal year.

Maximus Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Saturday, May 31st. Shareholders of record on Thursday, May 15th will be paid a dividend of $0.30 per share. The ex-dividend date is Thursday, May 15th. This represents a $1.20 dividend on an annualized basis and a yield of 1.75%. Maximus’s dividend payout ratio (DPR) is presently 25.81%.

Maximus Profile

Maximus, Inc operates as a provider of government services in the United States and internationally. It operates through three segments: U.S. Federal Services, U.S. Services, and Outside the U.S. The U.S. Services segment offers program eligibility support and enrollment; centralized multilingual customer contact centers, multichannel, and digital self-service options for enrollment; application assistance and independent health plan choice counseling; beneficiary outreach, education, eligibility, enrollment, and redeterminations; and person-centered independent disability, long-term sick, and other health assessments.